Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Advanced Biomed Inc. (ADVB) had Return on Tangible Equity of -5.31% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.49M |
|
-- |
|
-- |
|
$0.52M |
|
$-0.52M |
|
$0.03M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
$-0.52M |
|
$-0.51M |
|
1.28M |
|
1.28M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$10.53M |
|
$0.09M |
|
$0.12M |
|
$10.65M |
|
$1.43M |
|
-- |
|
$0.01M |
|
$1.44M |
|
$9.21M |
|
$9.21M |
|
$9.21M |
|
1.38M |
|
| Cash Flow Statement Financials | |
$-1.36M |
|
$-0.02M |
|
$1.03M |
|
$2.90M |
|
$2.61M |
|
$-0.30M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.31% |
|
|
Return on Tangible Equity |
-5.31% |
-4.59% |
|
-5.31% |
|
$6.66 |
|
$-1.07 |
|
$-1.06 |
|